These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 6788934)
21. [Derivatives of 2-mercaptobenzenesulphonylamide. IV. Synthesis and properties of some hypoglycemic agents derived from N-(4-chloro-2-mercapto-5-methylbenzenesulphonyl)urea]. Brzozowski Z; Wójcikowski C Acta Pol Pharm; 1990; 47(3-4):45-8. PubMed ID: 12959242 [TBL] [Abstract][Full Text] [Related]
22. Synthesis, structural characterization and in vivo anti-diabetic evaluation of some new sulfonylurea derivatives in normal and silicate coated nanoparticle forms as anti-hyperglycemic agents. Sroor FM; Abbas SY; Basyouni WM; El-Bayouki KAM; El-Mansy MF; Aly HF; Ali SA; Arafa AF; Haroun AA Bioorg Chem; 2019 Nov; 92():103290. PubMed ID: 31561109 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological evaluation of sulfonylurea and thiourea derivatives substituted with benzenesulfonamide groups as potential hypoglycemic agents. Zhang HB; Zhang YA; Wu GZ; Zhou JP; Huang WL; Hu XW Bioorg Med Chem Lett; 2009 Mar; 19(6):1740-4. PubMed ID: 19216076 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of some acylamide derivatives as potential hypoglycemic agents. Srivastava V; Suresh AJ; Pandeya SN; Pandey A Boll Chim Farm; 1996; 135(7):452-7. PubMed ID: 9035557 [TBL] [Abstract][Full Text] [Related]
32. Effect of glurenorm on immunohistochemical changes in pancreatic beta cells of rats in experimental diabetes. Koyuturk M; Ozsoy-Sacan O; Bolkent S; Yanardag R Indian J Exp Biol; 2005 Mar; 43(3):268-71. PubMed ID: 15816415 [TBL] [Abstract][Full Text] [Related]
33. Adamantane-Isothiourea Hybrid Derivatives: Synthesis, Characterization, In Vitro Antimicrobial, and In Vivo Hypoglycemic Activities. Al-Wahaibi LH; Hassan HM; Abo-Kamar AM; Ghabbour HA; El-Emam AA Molecules; 2017 Apr; 22(5):. PubMed ID: 28468231 [TBL] [Abstract][Full Text] [Related]
34. Synthesis and hypoglycemic activity of some new theophylline derivatives. Alafeefy AM; Alqasoumi SI; Abdel Hamid SG; El-Tahir KE; Mohamed M; Zain ME; Awaad AS J Enzyme Inhib Med Chem; 2014 Jun; 29(3):443-8. PubMed ID: 23701264 [TBL] [Abstract][Full Text] [Related]
36. Potentially active hypoglycemic agents from N1-nicotinoyl-2-pyrazolin-5-one derivatives and their N1-(oxynicotinoyl) analogues. Girges MM; Hanna MA; Rasala D; Berghot M Arzneimittelforschung; 1992 Nov; 42(11):1350-3. PubMed ID: 1492850 [TBL] [Abstract][Full Text] [Related]
37. New potent antihyperglycemic agents in db/db mice: synthesis and structure-activity relationship studies of (4-substituted benzyl) (trifluoromethyl)pyrazoles and -pyrazolones. Kees KL; Fitzgerald JJ; Steiner KE; Mattes JF; Mihan B; Tosi T; Mondoro D; McCaleb ML J Med Chem; 1996 Sep; 39(20):3920-8. PubMed ID: 8831758 [TBL] [Abstract][Full Text] [Related]
38. Hypoglycaemic activity of carbothioamides and related 1,2,4-thiodiazolidines. Chaubey M; Pandeya SN Farmaco; 1989 Oct; 44(10):987-95. PubMed ID: 2619864 [TBL] [Abstract][Full Text] [Related]
39. Synthesis, hypoglycemic activity and molecular modeling studies of pyrazole-3-carbohydrazides designed by a CoMFA model. Hernández-Vázquez E; Aguayo-Ortiz R; Ramírez-Espinosa JJ; Estrada-Soto S; Hernández-Luis F Eur J Med Chem; 2013 Nov; 69():10-21. PubMed ID: 23995214 [TBL] [Abstract][Full Text] [Related]
40. A short series of antidiabetic sulfonylureas exhibit multiple ligand PPARgamma-binding patterns. Arrault A; Rocchi S; Picard F; Maurois P; Pirotte B; Vamecq J Biomed Pharmacother; 2009 Jan; 63(1):56-62. PubMed ID: 18280694 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]